InBristol-Myers Squibb
Celgene
Juno Therapeutics
PlayingShare
CNBC
CNBC LLC
All Rights Reserved
Division
NBCUniversalData
Global Business and Financial News
Market Data and Analysis
Celgene
Giovanni Caforio
Watch Next
No matching tags
No matching tags
No matching tags
No matching tags
No matching tags
Bristol-Myers on Thursday announced plans to buy Celgene in a deal valued at $74 billion.
As said here by Berkeley Lovelace Jr.